TY - JOUR AU - Passaro, Antonio AU - de Marinis, Filippo PY - 2018 TI - Dacomitinib in EGFR-positive non-small cell lung cancer: an attractive but broken option JF - Translational Lung Cancer Research; Vol 7, Supplement 2 (April 23, 2018): Translational Lung Cancer Research Y2 - 2018 KW - N2 - The identification of EGFR mutations in non-small cell lung cancer (NSCLC) changed deeply the treatment of this disease harbouring these kind of DNA alterations, that occur respectively in about 10–15% and 45–50% of Caucasian and Asian patients (1,2). UR - https://tlcr.amegroups.org/article/view/19489